Furthering its strong corporate story, Welset Plast Extrusion Pvt. Ltd. added another milestone, when on 6thJune, 2018 it signed an agreement to divest its PVC compound business to the globally acclaimed Mitsubishi Chemical Corporation (MCC), Japan.
Divesting this business to MCC is testimony to the value proposition that Welset has built across its businesses for all its stakeholders; something that has been an integral part of the Welset thought process.
The distinguished position of Welset medical PVC compound business that was nurtured since 1998, its position of market leadership in the medical compounding field in India & ASEAN markets and the expansive marketing channels and infrastructure will provide Mitsubishi Chemical Corporation a platform that they were looking for to expand its footprint in India. Paresh Mehta, Director, Welset Plast Extrusion Pvt. Ltd. would also be on the Board of Directors of the Indian entity of Mitsubishi Chemical Corporation for the PVC compounds and TPE business.
The customers would benefit significantly with a fortified product range as well as the expertise that MCC would bring to the TPE business; and Welset will continue to explore with MCC further business opportunities.
“Welset is set to invest further in its masterbatch business and increase its capacity from the current 25000 MTPA to 45000 MTPA. Notable being launch of its Oxo Bio-degradable masterbatch, a new range of products, grades for dedicated applications in plasticulture and an exponential rise in its global presence are some areas that would see increased activities,” highlights Arvind Mehta, Chairman, Welset Plast Extrusion Pvt. Ltd. In addition, Welset continues to witness a strong surge in its exports business.
For the existing business of masterbatches, all contacts and co-ordinates, products and processes remain unchanged.
Welset Plast Extrusions Pvt Ltd is today, a leading company in the business of masterbatches. It is one of India’s largest and most respected masterbatch manufacturers.
With an installed capacity of over 25,000 MTA, the company is well geared to aggressively address the dynamic supply-demand variances. Innovation in compounding continues to be the key philosophy that runs through the company operations.